Cargando…
Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer’s disease model
BACKGROUND: Microglia mediate amyloid-beta peptide (Aβ)-induced neuroinflammation, which is one of the key events in the pathogenesis of Alzheimer’s disease (AD). Decoy receptor 3 (DcR3)/TNFRSF6B is a pleiotropic immunomodulator that promotes macrophage differentiation toward the M2 anti-inflammator...
Autores principales: | Liu, Yi-Ling, Chen, Wei-Ting, Lin, Yu-Yi, Lu, Po-Hung, Hsieh, Shie-Liang, Cheng, Irene Han-Juo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402663/ https://www.ncbi.nlm.nih.gov/pubmed/28438208 http://dx.doi.org/10.1186/s13024-017-0173-0 |
Ejemplares similares
-
GATA4 and DcR1 methylation in glioblastomas
por: Vaitkienė, Paulina, et al.
Publicado: (2013) -
Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis
por: Su, Jingqian, et al.
Publicado: (2023) -
Role of TGFβ3-Smads-Sp1 axis in DcR3-mediated immune escape of hepatocellular carcinoma
por: Zhu, Hui-fang, et al.
Publicado: (2019) -
Membrane expression of TRAIL receptors DR4, DR5, DcR1 and DcR2 in the normal endometrium, atypical endometrial hyperplasia and endometrioid adenocarcinoma: a tissue microarray study
por: Gottwald, Leszek, et al.
Publicado: (2013) -
Overexpression of DcR3 and Its Significance on Tumor Cell Differentiation and Proliferation in Glioma
por: Huang, Suning, et al.
Publicado: (2014)